Revenue and net profit saw strong double-digit growth year-over-year and sequentially, with EPS more than doubling. Expansion activities included new investments and share allotments, while a major corporate restructuring awaits regulatory approval.Original document: Laurus Labs Ltd. [LAURUSLABS] I…
Revenue and net profit saw strong double-digit growth year-over-year and sequentially, with EPS more than doubling. Expansion activities included new investments and share allotments, while a major corporate restructuring awaits regulatory approval.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.